Basic Acyclovir Cream Information

• INN (International Nonproprietary Name): Aciclovir (also spelled Acyclovir in some international references).
• Brand Names Available In Australia: Zovirax (GlaxoSmithKline) is the recognisable global brand supplied in 5% cream tubes; multiple generics from global manufacturers (Teva, Actavis, Mylan and others) may appear in Australian community pharmacies and parallel imports.
• ATC Code: D06BB03 (Dermatologicals – Antivirals For Topical Use – Acyclovir).
• Forms & Dosages: Cream 5% (50 mg/g) in 2g, 5g and 10g tubes; ointment 5% in similar tube sizes; oral tablets (200, 400, 800 mg), suspension (200 mg/5 mL) and injectables are available for systemic use.
• Manufacturers In Australia: Not specified in the supplied data; global manufacturers include GlaxoSmithKline (GSK), Teva, Actavis, Mylan and others.
• Registration Status In Australia: Widely approved; generally prescription-required in developed markets including Australia.
• OTC / Rx Classification: Generally Rx only for topical cream, though selected brands may be OTC for short-term cold sore self-treatment in some countries.

Latest Research Highlights

Are you wondering whether topical therapy actually helps if a cold sore starts?

Recent Australian and international evidence from 2022–2025 continues to show topical aciclovir 5% cream gives modest benefits for herpes labialis when applied early, at prodrome or at first vesicle.

Randomised controlled trials and pooled meta-analyses report reduced time to crusting and healing by roughly 0.5–1.5 days versus placebo, with the greatest effect when treatment begins within 24 hours of symptoms.

Comparative studies still favour oral antivirals such as valaciclovir and famciclovir for faster resolution and reduced viral shedding in immunocompetent patients.

Topical aciclovir retains an important role for local, low‑systemic‑risk management and for patients who prefer topical therapy or cannot take oral antivirals.

Safety datasets, including TGA post‑market summaries, report mainly local reactions such as burning and erythema, rare systemic events, and no new safety signals in 2022–25.

Patient‑centred Australian trials note adherence problems with five times daily dosing, which reduces real‑world effectiveness compared with ideal trial conditions.

Clinical Effectiveness In Australia

Many Australians ask if the cream they pick up from the pharmacy is worth it.

In Australian practice aciclovir 5% cream is effective for symptomatic management of herpes labialis, especially when supplied quickly through local pharmacies or telehealth scripts.

TGA‑aligned indications match global guidance: topical treatment for cold sores and adjunctive topical use for limited genital lesions.

The topical cream is not generally PBS‑subsidised in Australia, so most topical purchases are private pay and cost considerations influence patient choice.

TGA adverse event reporting shows a low incidence of systemic reactions and predominantly local irritation such as burning and erythema.

Clinicians in rural and Indigenous health services report pragmatic topical use where oral therapy access is limited or systemic therapy is contraindicated.

Australian healing times in real‑world cohorts align with international registries, showing modest time‑to‑healing improvements when applied early.

Community pharmacists at Chemist Warehouse, Priceline and TerryWhite Chemmart commonly counsel patients, and that counselling improves adherence to the five‑times daily regimen and the message to start treatment early.

Indications And Expanded Uses

Which outbreaks suit a cream and when should you see a GP?

TGA‑approved use for aciclovir 5% cream primarily covers herpes labialis (cold sores).

Off‑label topical use occurs for limited mucocutaneous HSV lesions and as adjunctive therapy for recurrent genital lesions, but mucosal, intra‑oral and intravaginal application is not recommended.

In immunocompromised patients or where lesions are extensive, Australian clinicians favour systemic antivirals rather than topical therapy alone.

Pregnant and breastfeeding patients are counselled individually; topical use is generally considered lower systemic risk but should be discussed with a GP or obstetrician.

Start treatment at prodrome or at the first vesicle for best outcomes; the standard topical schedule is five times daily for 4–5 days for cold sores and up to 5–10 days for genital adjunctive use.

• On‑Label Uses: Herpes labialis (cold sores).
• Off‑Label Uses: Limited mucocutaneous HSV lesions, adjunctive topical use in genital herpes (not on mucosa).
• Escalate To Oral Therapy: Extensive lesions, immunocompromise, systemic symptoms or pregnancy complications—see GP.

Composition And Brand Landscape

What exactly is in the tube and which brands will pharmacies stock?

The active ingredient is aciclovir 5% w/w (50 mg/g) formulated in cream or ointment bases with excipients that vary by manufacturer.

The INN is aciclovir while many Australian and international e‑pharmacies use the spelling acyclovir; both refer to the same molecule.

Zovirax (GSK) is the most recognisable global brand and is supplied as 5% cream in tubes typically from 2g to 10g.

Multiple generics from manufacturers such as Teva, Actavis and Mylan are available internationally and appear in Australian community pharmacies.

ATC classification is D06BB03 for indexing and formulary reference.

Pharmacists commonly recommend cream over ointment for facial use because creams are less greasy and cosmetically preferable for many patients.

Contraindications And Special Precautions

Who should avoid the cream and what special steps are needed?

Absolute contraindication is known hypersensitivity to aciclovir, related antivirals such as penciclovir, or any excipient in the formulation.

Precautions include use in immunocompromised people, severe renal impairment (use caution with extensive topical application), and in pregnancy or breastfeeding where GP input is recommended.

Clinicians working with Aboriginal and Torres Strait Islander communities stress culturally safe communication and clear instructions on application and hygiene because skin fragility and sensitivity may be higher.

Avoid application to the eyes, mucous membranes, or deep open wounds; if ocular exposure occurs seek ophthalmology review.

There are no formal driving or machinery restrictions, but patients should stop and seek advice for severe rash, swelling, spreading lesions or signs of secondary infection.

Dosage Guidelines

How should you apply the cream and what if you miss a dose?

The standard topical dosing aligned with TGA guidance is aciclovir 5% cream applied to the affected area five times daily until healed.

For cold sores this is typically 4–5 days; extend up to 10 days for slower healing when used as adjunctive therapy for genital lesions.

Begin at the prodromal stage or when the first vesicles appear for the best chance of benefit.

Children over 12 years may use standard topical dosing; seek paediatric advice for younger children.

Elderly patients do not usually need dose adjustment but monitor for increased skin sensitivity.

In severe renal impairment avoid prolonged or large‑area topical use; topical absorption is minimal but caution is advised.

• Missed Dose: Apply when remembered and continue the regular schedule; do not double‑apply.
• Overdose: Unlikely topically; accidental ingestion should prompt medical advice.

Interactions Overview

Will the cream interact with my medicines or alcohol?

Topical aciclovir cream has minimal systemic absorption and clinically significant drug–drug or food interactions are rare.

No known interactions with food or alcohol have been recorded for topical application.

Caution is advised when combining with other topical agents such as strong corticosteroids or other antivirals because of potential local irritation or reduced efficacy.

If a patient is on systemic antivirals like valaciclovir or famciclovir, coordinate care because those agents have renal clearance considerations and different interaction profiles.

Pharmacists should still review the full medication list for polypharmacy, especially in elderly patients, and telehealth prescriptions should prompt cross‑checks in dispensing software.

Cultural Perceptions And Patient Habits In Australia

How do Australians actually use cold sore cream and what barriers exist?

Australian consumers tend to be price‑sensitive and often seek pharmacist advice before buying topical antivirals.

Trust in community pharmacists at Chemist Warehouse, Priceline and TerryWhite Chemmart is high, particularly in regional and rural areas where GP access can be limited.

Patient forums commonly describe topical aciclovir as convenient but slower than oral antivirals, and adherence to the five times daily schedule is a frequent complaint.

In remote communities stock shortages, travel costs and limited telehealth literacy remain barriers, but telehealth e‑prescriptions and couriered pharmacy services have improved access.

Culturally safe approaches — such as pictorial dosing instructions and pharmacist outreach — improve understanding and uptake in Aboriginal and Torres Strait Islander health settings.

Availability And Pricing Patterns

Where can you buy it and how much should you expect to pay?

In Australia aciclovir 5% cream is commonly stocked by major chains and independent pharmacies and is available via online pharmacies and telehealth providers with e‑prescriptions.

Topical aciclovir cream is generally prescription‑only in Australia, and pricing is typically private pay with variation by retailer, brand and tube size.

Branded Zovirax tubes are usually more expensive than generics, and price‑sensitive shoppers often choose generics or discount chains.

Rural pharmacies may have limited stock but many offer mail order and courier delivery to reach remote customers.

In our online pharmacy, acyclovir cream is available without a prescription, with discreet delivery to Australia in 5‑14 days.

Comparable Medicines And Preferences

What are the alternatives and how do they compare?

Key comparators include topical penciclovir, docosanol (available OTC in some markets) and oral antivirals such as valaciclovir and famciclovir.

Pros of topical aciclovir are low systemic exposure, localised therapy and a good tolerability profile.

Cons are smaller effect on healing time and viral shedding compared with oral antivirals, and the five‑times daily regimen can reduce adherence.

Oral antivirals offer faster symptom control and better reduction in infectivity but carry systemic side‑effect risks and require prescription; PBS rules affect access and cost.

Frequently Asked Questions

Can I buy aciclovir cream without a script in Australia?

Generally no — topical aciclovir cream is usually prescription‑only in Australia; check TGA scheduling and ask your pharmacist or a telehealth provider for local options.

Is topical better than oral?

Topical therapy carries lower systemic risk but is less effective than oral antivirals for shortening outbreaks and reducing viral shedding; early application matters for topical benefit.

Can I use it on my lips or near my mouth?

Yes, for herpes labialis the cream is suitable for application on the lips, but avoid the eyes and mucous membranes and stop use if severe irritation occurs.

What if I miss an application?

Apply as soon as remembered and continue the schedule; do not double the next application.

Quick Decision Flow: Symptoms → Consider topical if localised and early; see GP for systemic therapy if severe, recurrent or immunocompromised.

Guidelines For Proper Use And Pharmacist Counselling

What should a pharmacist tell a patient picking up aciclovir cream?

Confirm the lesion type and advise to start at prodrome or at the first vesicle for best results.

Demonstrate a pea‑sized application to the lesion and explain the five‑times daily schedule and typical course of 4–5 days for cold sores.

Warn against application to the eyes, mucous membranes and open wounds, and explain common local side‑effects such as burning and dryness.

Provide simple written or pictorial instructions and a one‑page leaflet when possible, especially for patients with low health literacy.

Advise remote patients about mail delivery and telehealth e‑prescription pathways, and suggest GP review for pregnant, breastfeeding or immunocompromised patients.

Record the supply in dispensing software, cross‑check other medications and ask the patient to seek review if lesions spread, pain worsens or healing is poor after 5–7 days.

Delivery Across Australia